Interestingly, the percentage of cells displaying nuclear GLI1 staining positively correlated with ErbB2 expression in carcinoma samples (p = 0.027), and this result suggests the involvement of Hh pathway activation in the development of ErbB2-positive breast cancer. Here, ERBB2 is linked to carcinoma.